Parameters | Mean | SD |
---|---|---|
No COVID-19(n) | 207(38.3%) | |
COVID-19 and no vaccination(n) | 185(34.3%) | |
COVID-19 and vaccination(n) | 148(27.4%) | |
Age (years) | 55.9 | ± 14.9 |
Sex-Male | 223(41.3%) | |
Neurological deficits (n, %) | 301(55.7%) | |
Malignance (n, %) | 196(36.3%) | |
Total TV (cc) | 16.6 | ± 2.97 |
Peripheral dose (GY) | 16.2 | ± 5.2 |
Number of lesions | 1.6 | ± 1.5 |
KPS | 83.8 | ± 8.1 |
ECOG | 0.8 | ± 0.9 |
Charlson comorbidity index | 3.9 | ± 3.2 |
Time from diagnosis to GK treatment (days) | 44.0 | ± 26.2 |
Time from diagnosis to GK consultation (days) | 22.5 | ± 23.2 |
Duration of GK treatment (hours) | 5.0 | ± 1.4 |
OPD frequency (time/year) | 10.4 | ± 7.3 |
MRI frequency (time/year) | 2.0 | ± 1.3 |